Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa for Malignant Pleural Effusion in NSCLC
NCT01004510Phase 2Terminated
- Sponsor
- Peter Bushunow
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in malignant pleural effusion (MPE), sponsored by Peter Bushunow. Started Nov 2009; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT01004510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004510.